How to Foster Communication Among all Members of the Cancer Care Team with Pathologists to Deliver Individualized Treatment for Patients with Lung Cancer

David L. Rimm, MD, PhD; Roy Herbst, MD, PhD

Video Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library

Drs Roy Herbst and David Rimm consider novel ways that surgeons, interventional radiologists, pulmonologists, medical oncologists, and pathologists interact at Yale Cancer Center to maximize the use of common molecular biomarkers, as well as NGS and TMB, in providing precision medicine to lung cancer patients.

September 20, 2013

Absorbing the Cost of Personalized Medicine

Matthew Palmgren discusses the benefits of personalized medicines

January 20, 2016

Which Part of Stem Cells Should Be Treated?

Dr Wainberg and Dr Gerson discuss the ongoing debate about whether clinicians should treat the surface or the internal structure of cancer stem cells.